Company insight
he pharmaceutical industry continues to evolve rapidly, driven by advances in drug formulation, personalised medicine and the growing demand for safe, efficient and patient-friendly drug delivery systems. In this dynamic environment, collaborating with a reliable and innovative contract development and manufacturing organisation (CDMO) is critical for pharma companies aiming to bring therapies to market efficiently and compliantly. Phillips Medisize stands out as a global leader in the design, development and manufacturing of advanced drug delivery devices, from platform solutions to bespoke device development, clinical to commercial scale manufacturing and assembly, labelling and packaging solutions tailored for unique customer needs. Phillips Medisize’s customers include 80% of the top ten most valuable pharmaceutical companies. In 2024, the company helped biopharma customers: ■
develop more than 441 million life-saving and life-enhancing drug delivery devices
■ ■
care for 32 million insulin-dependent patients
deliver 3.4 million emergency doses of life-saving epinephrine
Pharma industry’s unique needs Pharmaceutical companies face complex challenges that extend beyond drug formulation. Devices that deliver drugs, such as syringes, inhalers and injectors, must meet stringent regulatory standards, ensure
Commitment to excellence T
Phillips Medisize offers complete CDMO solutions for the pharmaceutical industry.
patient safety and maintain drug stability. Additionally, the growing trend towards biologics, speciality medicines and self- administration therapies requires highly specialised device solutions that integrate seamlessly with pharmaceuticals. Phillips Medisize’s comprehensive offerings can address these challenges head-on by combining cutting-edge engineering, extensive regulatory expertise and scalable global manufacturing capabilities.
Customised drug delivery device At the core of Phillips Medisize’s pharmaceutical solutions is its expertise in advanced drug delivery solutions, from custom devices to solutions for complex manufacturing or inhaled formulation challenges. Phillips Medisize engineering and formulation teams collaborate closely with their pharmaceutical customers to transform clinical requirements into patient-centric device designs that aim to optimise usability, safety and therapeutic efficacy. To meet the evolving customer needs, Phillips Medisize has developed a suite of platform technologies it can utilise to develop drug delivery devices. These modular assets take the form of functional subsystems, drivetrains and assemblies. Some of these enabling technologies can already be found in a range of products, including its proprietary platform products and bespoke devices developed for customers, helping to provide confidence in feasibility.
Manufacturing and supply expertise Phillips Medisize offers full life-cycle support from design and prototyping to high- volume manufacturing and supply chain management. This integrated approach helps reduce time to market and can assist with mitigating the risks associated with device complexity and regulatory compliance. Capabilities include: ■
Precision injection moulding: utilising advanced materials to create components with tight tolerances and biocompatibility.
■
Assembly and automation: combining automated and manual assembly processes to maintain quality and scalability.
■ ■
Sterilisation and packaging: validated processes to ensure device sterility and product integrity.
Regulatory compliance and quality systems: adherence to ISO 13485, FDA regulations and global standards to support client submissions and audits.
The global manufacturing footprint across the US, Europe and Asia supports seamless supply continuity and helps reduce logistical complexities, especially important for time-sensitive pharmaceutical products.
Your trusted CDMO solution Phillips Medisize stands as a trusted CDMO for pharmaceutical companies navigating the complexities of modern drug delivery. Its comprehensive services, from innovative device design to robust manufacturing and regulatory support, enable pharmaceutical innovators to streamline development, ensure compliance and ultimately deliver therapies that can improve patient outcomes. By choosing Phillips Medisize, pharmaceutical companies gain more than a contract development and manufacturer; they gain a company committed to advancing healthcare and committed to innovative, safe and patient-friendly drug delivery solutions. ●
References available on request. Expertise from discovery to delivery.
www.worldpharmaceuticals.net
phillipsmedisize.com/ pharmaceutical
21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85
